Revvity | PKI - 流动资产



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 14.1B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


流动资产 更改 日
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
Bio Techne USD 688.05M 50.62M 2026-03
Bio-Rad Laboratories USD 2.94B 35.9M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Celltrion KRW 470.6B 5.07T 2025-12
Charles River Laboratories USD 1.49B 41.76M 2026-03
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 1.85B 178M 2026-03
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Illumina USD 2.74B 551M 2026-03
Intuitive Surgical USD 11.52B 881.5M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Laboratory Of America USD 4.56B 538.3M 2026-03
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Mesa Laboratories USD 105.63M 8.2M 2025-12
Mettler Toledo International USD 1.33B 30.76M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
OraSure Technologies USD 240.78M 21.13M 2026-03
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pacific Biosciences Of California USD 369.52M 5.54M 2026-03
Pharma Mar EUR 273.45M 9.96M 2026-03
Qiagen NV USD 2B 535.87M 2025-12
Quest Diagnostics USD 2.57B 188M 2026-03
Quidel USD 1.38B 70.3M 2026-03
Repligen USD 1.16B 23.98M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Tilray USD 729.32M 28.18M 2025-09
Waters USD 3.72B 1.73B 2026-03
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03